Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals

THE SPECTRUM OF THE DISEASE IN 98 PATIENTS

1970 • 998 citations

Azole antifungal agents: emphasis on new triazoles

1988 • 468 citations

Invasive Aspergillosis in Acute Leukemia: Correlation with Nose Cultures and Antibiotic Use

1979 • 281 citations

Activity of Orally, Topically, and Parenterally Administered Itraconazole in the Treatment of Superficial and Deep Mycoses: Animal Models

1987 • 212 citations

Itraconazole, a new triazole that is orally active in aspergillosis

1984 • 160 citations

Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones

1984 • 138 citations

In vitro studies with R 51,211 (itraconazole)

1984 • 134 citations

Antifungal relative inhibition factors: BAY 1–9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14–4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents

1984 • 81 citations

Aspergillus Pneumonia in Hematologic Malignancy

1977 • 65 citations

Itraconazole treatment of murine aspergillosis

1985 • 39 citations

Antifungal Activity of Enilconazole on Experimental Aspergillosis in Chickens

1983 • 31 citations

In-Vitro and In-Vivo Models to Study the Activity of Antifungals against Aspergillus

1988 • 24 citations

Role of Animal and Human Pharmacology in Antifungal Drug Design

1988 • 12 citations

In Vitro Activity of Enilconazole*Against Aspergillus Spp. and its Fungicidal Efficacy in a Smoke Generator Against Aspergillus fumigatus./Die In Vitro‐Aktivität von Enilconazol*gegen Aspergillus spp. und seine fungizide Aktivität gegen Aspergillus fumigatus bei Verräucherung

1988 • 9 citations

Etude de l'activite antifongique par le modele-animal pre-clinique

1987 • 1 citations

Deleted Work

1955 • 0 citations